Warsaw Orthopedic, Inc. v Nuvasiive, Inc., No. 13-1576 (Fed. Cir. 2015)
Annotate this CaseWarsaw owns the 973 patent, which claims oversized spinal implants, and the 933 patent, which claims methods and devices for retracting tissue to create a working channel for minimally invasive spinal surgery. NuVasive owns the 236 patent, which relates to neuromonitoring during surgery. Warsaw sued NuVasive, alleging infringement; NuVasive counterclaimed, asserting infringement. A jury found that the asserted claims of the 973 patent were not invalid (infringement was not in dispute), that the asserted claims of the 933 patent were infringed under the doctrine of equivalents (validity was not in dispute), and that the asserted claims of the 236 patent were infringed (validity was not in dispute), and awarded damages for each. The district court denied motions for JMOL or a new trial; denied Warsaw’s requests for supplemental damages and a permanent injunction; and set ongoing royalty rates. The Federal Circuit affirmed with respect to invalidity and infringement of all three patents, but remanded for a new trial on damages with respect to the 973 and 933 patents. On remand, Warsaw will be limited to a reasonable royalty and cannot recover lost profits.
The court issued a subsequent related opinion or order on June 3, 2016.
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.